Trinity Biotech plc (TRIB)
USD 0.81
(-4.35%)
USD 0.81
(-4.35%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -24.09 Million USD | -62.91% |
| 2022 | -16.71 Million USD | -152.06% |
| 2021 | 10.59 Million USD | -28.33% |
| 2020 | 21.52 Million USD | 284.72% |
| 2019 | -19.52 Million USD | -22.27% |
| 2018 | -13.98 Million USD | 18.01% |
| 2017 | -29.27 Million USD | -36.63% |
| 2016 | -30.91 Million USD | -62.37% |
| 2015 | 19.14 Million USD | 45.35% |
| 2014 | 19.93 Million USD | -5.41% |
| 2013 | 19 Million USD | -1.4% |
| 2012 | 22.27 Million USD | 6.78% |
| 2011 | 20.8 Million USD | 18.41% |
| 2010 | 15.38 Million USD | 9.03% |
| 2009 | 14.1 Million USD | 119.74% |
| 2008 | -71.46 Million USD | -224.48% |
| 2007 | -20.99 Million USD | -372.3% |
| 2006 | 8.36 Million USD | -24.39% |
| 2005 | 10.85 Million USD | 5.61% |
| 2004 | 8.63 Million USD | -21.83% |
| 2003 | 11.89 Million USD | 26.21% |
| 2002 | 10.02 Million USD | 18.03% |
| 2001 | 8.69 Million USD | -11.05% |
| 2000 | 8.46 Million USD | 56.1% |
| 1999 | 6.66 Million USD | 69.34% |
| 1998 | 3.7 Million USD | 131.25% |
| 1997 | 900 Thousand USD | 633.33% |
| 1996 | -500 Thousand USD | 88.46% |
| 1995 | -1.6 Million USD | -62.5% |
| 1994 | -2.5 Million USD | 57.89% |
| 1993 | -4 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -1.52 Million USD | -69.89% |
| 2024 Q1 | -2.37 Million USD | 24.18% |
| 2023 Q1 | -3.16 Million USD | 20.87% |
| 2023 Q4 | -3.02 Million USD | 22.02% |
| 2023 Q3 | -3.88 Million USD | -11.2% |
| 2023 Q2 | -3.49 Million USD | -10.37% |
| 2023 FY | - USD | -62.91% |
| 2022 Q2 | -2.22 Million USD | -1386.13% |
| 2022 Q4 | -3.99 Million USD | -7.3% |
| 2022 FY | - USD | -152.06% |
| 2022 Q1 | 173 Thousand USD | -89.75% |
| 2022 Q3 | -3.72 Million USD | -67.42% |
| 2021 Q4 | 1.68 Million USD | -38.63% |
| 2021 Q1 | 3.07 Million USD | -66.04% |
| 2021 Q3 | 2.74 Million USD | -56.27% |
| 2021 FY | - USD | -28.33% |
| 2021 Q2 | 6.28 Million USD | 104.19% |
| 2020 Q2 | 503 Thousand USD | -70.82% |
| 2020 FY | - USD | 284.72% |
| 2020 Q3 | 9.08 Million USD | 1706.76% |
| 2020 Q1 | 1.72 Million USD | 12.53% |
| 2020 Q4 | 9.06 Million USD | -0.24% |
| 2019 FY | - USD | -22.27% |
| 2019 Q2 | 1.33 Million USD | -8.36% |
| 2019 Q1 | 1.46 Million USD | -29.64% |
| 2019 Q4 | 1.53 Million USD | 6.61% |
| 2019 Q3 | 1.43 Million USD | 7.4% |
| 2018 Q1 | 2.01 Million USD | 94.49% |
| 2018 Q3 | 1.41 Million USD | -26.59% |
| 2018 Q4 | 2.07 Million USD | 47.06% |
| 2018 Q2 | 1.92 Million USD | -4.43% |
| 2018 FY | - USD | 18.01% |
| 2017 FY | - USD | -36.63% |
| 2017 Q2 | 2.02 Million USD | 36.57% |
| 2017 Q3 | 1.74 Million USD | -14.2% |
| 2017 Q4 | 1.03 Million USD | -40.57% |
| 2017 Q1 | 1.48 Million USD | -73.83% |
| 2016 Q3 | 2.93 Million USD | -14.33% |
| 2016 FY | - USD | -62.37% |
| 2016 Q2 | 3.42 Million USD | 67.24% |
| 2016 Q1 | 2.04 Million USD | -51.75% |
| 2016 Q4 | 5.67 Million USD | 93.65% |
| 2015 Q1 | 4.33 Million USD | -0.21% |
| 2015 FY | - USD | 45.35% |
| 2015 Q3 | 13.68 Million USD | 235.38% |
| 2015 Q2 | 4.08 Million USD | -5.88% |
| 2015 Q4 | 4.23 Million USD | -69.04% |
| 2014 FY | - USD | -5.41% |
| 2014 Q1 | 4.54 Million USD | -11.88% |
| 2014 Q4 | 4.34 Million USD | -6.6% |
| 2014 Q3 | 4.65 Million USD | 0.37% |
| 2014 Q2 | 4.63 Million USD | 1.94% |
| 2013 Q4 | 5.16 Million USD | -0.17% |
| 2013 Q1 | 4.53 Million USD | -7.76% |
| 2013 FY | - USD | -1.4% |
| 2013 Q3 | 5.16 Million USD | 20.04% |
| 2013 Q2 | 4.3 Million USD | -5.13% |
| 2012 FY | - USD | 6.78% |
| 2012 Q4 | 4.92 Million USD | 1.26% |
| 2012 Q3 | 4.86 Million USD | -0.84% |
| 2012 Q2 | 4.9 Million USD | 8.84% |
| 2012 Q1 | 4.5 Million USD | 18.72% |
| 2011 Q4 | 3.79 Million USD | -18.41% |
| 2011 Q3 | 4.64 Million USD | 2.88% |
| 2011 Q1 | 4.34 Million USD | 4.93% |
| 2011 Q2 | 4.51 Million USD | 4.1% |
| 2011 FY | - USD | 18.41% |
| 2010 Q2 | 3.77 Million USD | 2.47% |
| 2010 Q1 | 3.68 Million USD | 5.65% |
| 2010 Q3 | 3.78 Million USD | 0.11% |
| 2010 Q4 | 4.13 Million USD | 9.42% |
| 2010 FY | - USD | 9.03% |
| 2009 Q1 | 3.04 Million USD | 103.55% |
| 2009 FY | - USD | 119.74% |
| 2009 Q2 | 3.84 Million USD | 26.32% |
| 2009 Q3 | 3.73 Million USD | -2.94% |
| 2009 Q4 | 3.48 Million USD | -6.49% |
| 2008 Q2 | 2.21 Million USD | 30.85% |
| 2008 Q3 | 1.95 Million USD | -11.79% |
| 2008 Q4 | -85.61 Million USD | -4483.82% |
| 2008 FY | - USD | -224.48% |
| 2008 Q1 | 1.69 Million USD | 100.98% |
| 2007 Q3 | 34.73 Million USD | 863.52% |
| 2007 Q4 | -172.98 Million USD | -598.03% |
| 2007 Q2 | 3.6 Million USD | 11.27% |
| 2007 Q1 | 3.24 Million USD | 223.03% |
| 2007 FY | - USD | -372.3% |
| 2006 Q2 | -3.78 Million USD | -347.97% |
| 2006 Q1 | 1.52 Million USD | 155.18% |
| 2006 Q3 | 2.92 Million USD | 177.22% |
| 2006 Q4 | 1 Million USD | -65.67% |
| 2006 FY | - USD | -24.39% |
| 2005 Q3 | 2.34 Million USD | 25.23% |
| 2005 Q2 | 1.87 Million USD | -10.22% |
| 2005 Q1 | 2.08 Million USD | 19.29% |
| 2005 FY | - USD | 5.61% |
| 2005 Q4 | 598 Thousand USD | -74.48% |
| 2004 Q4 | 1.74 Million USD | -32.02% |
| 2004 Q1 | 1.12 Million USD | -70.22% |
| 2004 Q2 | 2.05 Million USD | 83.33% |
| 2004 Q3 | 2.57 Million USD | 24.94% |
| 2004 FY | - USD | -21.83% |
| 2003 Q3 | 2.69 Million USD | 2.97% |
| 2003 Q4 | 2.85 Million USD | 39.29% |
| 2003 Q1 | 2.8 Million USD | 72.82% |
| 2003 FY | - USD | 26.21% |
| 2003 Q2 | 2.55 Million USD | -8.72% |
| 2002 FY | - USD | 18.03% |
| 2002 Q2 | 2.24 Million USD | 5.71% |
| 2002 Q3 | 2.27 Million USD | 0.99% |
| 2002 Q1 | 2.14 Million USD | -1.49% |
| 2002 Q4 | 1.59 Million USD | -29.26% |
| 2001 FY | - USD | -11.05% |
| 2001 Q4 | 2.23 Million USD | 15.73% |
| 2001 Q3 | 1.9 Million USD | 17.14% |
| 2001 Q2 | 1.62 Million USD | -12.97% |
| 2001 Q1 | 1.49 Million USD | -36.82% |
| 2000 Q2 | 1.78 Million USD | 2.94% |
| 2000 Q1 | 1.73 Million USD | -26.83% |
| 2000 Q3 | 1.94 Million USD | 8.91% |
| 2000 FY | - USD | 56.1% |
| 2000 Q4 | 3 Million USD | 54.46% |
| 1999 Q2 | 1.4 Million USD | -6.67% |
| 1999 Q4 | 2.36 Million USD | 48.12% |
| 1999 FY | - USD | 69.34% |
| 1999 Q1 | 1.5 Million USD | 50.0% |
| 1999 Q3 | 1.6 Million USD | 14.29% |
| 1998 Q2 | 500 Thousand USD | -90.91% |
| 1998 FY | - USD | 131.25% |
| 1998 Q3 | 700 Thousand USD | 40.0% |
| 1998 Q1 | 5.5 Million USD | 147.01% |
| 1998 Q4 | 1 Million USD | 42.86% |
| 1997 Q2 | 4.1 Million USD | 32.26% |
| 1997 Q3 | 5 Million USD | 21.95% |
| 1997 FY | - USD | 633.33% |
| 1997 Q4 | -11.7 Million USD | -334.0% |
| 1997 Q1 | 3.1 Million USD | 155.36% |
| 1996 Q1 | 1.5 Million USD | 116.3% |
| 1996 Q4 | -5.6 Million USD | -394.74% |
| 1996 Q3 | 1.9 Million USD | 26.67% |
| 1996 FY | - USD | 88.46% |
| 1996 Q2 | 1.5 Million USD | 0.0% |
| 1995 Q2 | 2.4 Million USD | -4.0% |
| 1995 Q3 | 2.5 Million USD | 4.17% |
| 1995 FY | - USD | -62.5% |
| 1995 Q4 | -9.2 Million USD | -468.0% |
| 1995 Q1 | 2.5 Million USD | 0.0% |
| 1994 Q3 | 1.7 Million USD | 0.0% |
| 1994 FY | - USD | 57.89% |
| 1994 Q2 | 1.7 Million USD | 128.33% |
| 1994 Q1 | -6 Million USD | -1100.0% |
| 1993 Q4 | 600 Thousand USD | 0.0% |
| 1993 Q2 | 600 Thousand USD | 0.0% |
| 1993 FY | - USD | 0.0% |
| 1993 Q3 | 600 Thousand USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Bionano Genomics, Inc. | -213.6 Million USD | 88.718% |
| Prenetics Global Limited | -47.89 Million USD | 49.687% |
| Star Equity Holdings, Inc. | -1.68 Million USD | -1328.453% |
| CareDx, Inc | -89.65 Million USD | 73.122% |
| Exact Sciences Corporation | 41.87 Million USD | 157.546% |
| Exagen Inc. | -19.15 Million USD | -25.818% |
| Inotiv, Inc. | -26.5 Million USD | 9.085% |
| Guardant Health, Inc. | -433.3 Million USD | 94.439% |
| Biodesix, Inc. | -37.1 Million USD | 35.051% |
| BioNexus Gene Lab Corp. | -2.48 Million USD | -869.676% |
| Precipio, Inc. | -4.31 Million USD | -458.082% |
| iSpecimen Inc. | -9.1 Million USD | -164.705% |
| Natera, Inc. | -383.27 Million USD | 93.713% |
| Aspira Women's Health Inc. | -16.49 Million USD | -46.128% |
| Standard BioTools Inc. | -54.45 Million USD | 55.749% |
| 23andMe Holding Co. | -291.87 Million USD | 91.744% |
| Castle Biosciences, Inc. | -45.02 Million USD | 46.477% |
| Personalis, Inc. | -96.8 Million USD | 75.107% |
| Aclaris Therapeutics, Inc. | -117.56 Million USD | 79.502% |
| Applied DNA Sciences, Inc. | -9.59 Million USD | -151.255% |
| OpGen, Inc. | -29.51 Million USD | 18.342% |
| T2 Biosystems, Inc. | -43.87 Million USD | 45.076% |
| Myriad Genetics, Inc. | -67.8 Million USD | 64.457% |
| ICON Public Limited Company | 1.63 Billion USD | 101.477% |
| NeoGenomics, Inc. | -17.6 Million USD | -36.866% |
| Star Equity Holdings, Inc. | -1.68 Million USD | -1328.453% |
| IDEXX Laboratories, Inc. | 1.21 Billion USD | 101.979% |
| RadNet, Inc. | 292.78 Million USD | 108.231% |
| MDxHealth SA | -30.46 Million USD | 20.907% |
| Psychemedics Corporation | -251 Thousand USD | -9500.797% |
| Illumina, Inc. | -608 Million USD | 96.037% |
| Check-Cap Ltd. | -17.64 Million USD | -36.54% |
| Twist Bioscience Corporation | -176.7 Million USD | 86.363% |
| DarioHealth Corp. | -53.49 Million USD | 54.952% |
| Fulgent Genetics, Inc. | -46.55 Million USD | 48.234% |
| Sera Prognostics, Inc. | -35.28 Million USD | 31.709% |
| ENDRA Life Sciences Inc. | -9.78 Million USD | -146.28% |
| OPKO Health, Inc. | -65.51 Million USD | 63.218% |
| Medpace Holdings, Inc. | 363.15 Million USD | 106.636% |
| Neogen Corporation | 182.59 Million USD | 113.197% |
| Intelligent Bio Solutions Inc. | -8.81 Million USD | -173.508% |
| Prenetics Global Limited | -47.89 Million USD | 49.687% |
| Mainz Biomed B.V. | -25.01 Million USD | 3.651% |
| bioAffinity Technologies, Inc. | -7.62 Million USD | -215.861% |
| Neuronetics, Inc. | -22.75 Million USD | -5.883% |
| Sotera Health Company | 514.14 Million USD | 104.687% |
| bioAffinity Technologies, Inc. | -7.62 Million USD | -215.861% |